{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:36:44Z","timestamp":1792827404157,"version":"4.5.0"},"reference-count":99,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Medicines for Children Research Network"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:p>A number of anatomical and physiological factors determine the pharmacokinetic profile of a drug. Differences in physiology in paediatric populations compared with adults can influence the concentration of drug within the plasma or tissue. Healthcare professionals need to be aware of anatomical and physiological changes that affect pharmacokinetic profiles of drugs to understand consequences of dose adjustments in infants and children. Pharmacokinetic clinical trials in children are complicated owing to the limitations on blood sample volumes and perception of pain in children resulting from blood sampling. There are alternative sampling techniques that can minimize the invasive nature of such trials. Population based models can also limit the sampling required from each individual by increasing the overall sample size to generate robust pharmacokinetic data. This review details key considerations in the design and development of paediatric pharmacokinetic clinical trials.<\/jats:p>","DOI":"10.1111\/bcp.12267","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T23:34:39Z","timestamp":1383003279000},"page":"395-404","source":"Crossref","is-referenced-by-count":331,"title":["Paediatric pharmacokinetics: key considerations"],"prefix":"10.1111","volume":"79","author":[{"given":"Hannah Katharine","family":"Batchelor","sequence":"first","affiliation":[{"name":"Pharmacy, Pharmacology and Therapeutics School of Clinical and Experimental Medicine College of Medical and Dental Sciences University of Birmingham Medical School Building Edgbaston B15\u20092TT UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Francis","family":"Marriott","sequence":"additional","affiliation":[{"name":"Pharmacy, Pharmacology and Therapeutics School of Clinical and Experimental Medicine College of Medical and Dental Sciences University of Birmingham Medical School Building Edgbaston B15\u20092TT UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"EMA. ICH Topic E11. Clinical investigation of medicineal products in the paediatric population. CPMP\/ICH\/2711\/99.2001. Available athttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002926.pdf(last accessed 11 October 2013)."},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.04.048"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-010-9455-0"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.698261"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-006-1040-5"},{"issue":"5","key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0016-5085(76)80277-6","article-title":"Development of the human gastrointestinal tract. A review","volume":"70","author":"Grand RJ","year":"1976","journal-title":"Gastroenterology"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80424-9"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.1.3.447"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645110-00003"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(53)80422-1"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04332.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.58.8.0009"},{"key":"e_1_2_6_14_1","volume-title":"Paediatric Gastroenterology","author":"Navarro J","year":"1992"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.11.012"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.88.1.F52"},{"key":"e_1_2_6_17_1","first-page":"368","article-title":"Predicting human intestinal permeability using single\u2010pass intestinal perfusion in rat","volume":"10","author":"Zakeri\u2010Milani P","year":"2007","journal-title":"J Pharm Pharm Sci"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-191-8_6"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.59.3.236"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2001.tb00788.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/09542299.1991.11083160"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561477"},{"key":"e_1_2_6_23_1","first-page":"108","volume-title":"Oral Drug Absorption: Prediction and Assessment","author":"Edington AM","year":"2010"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31816a8cca"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.005611"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92302-I"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0090-9556(25)08415-6","article-title":"The nifedipine\u2010rifampin interaction: evidence for induction of gut wall metabolism","volume":"24","author":"Holtbecker N","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90162-9b"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.117937"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A\u2010dependent metabolism","volume":"283","author":"Paine MF","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2001.01370.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/66.2.185"},{"key":"e_1_2_6_33_1","first-page":"122","volume-title":"Nutrition in Pediatrics","author":"Puig M","year":"1996"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.94102s11107"},{"key":"e_1_2_6_35_1","first-page":"98","volume-title":"Handbook of Clinical Pharmacokinetics, Section II","author":"Morselli P","year":"1983"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198900171-00008"},{"key":"e_1_2_6_37_1","first-page":"17","volume-title":"Textbook of Pediatric Clinical Pharmacology","author":"Radde IC","year":"1985"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1971126897"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00565004"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1973.tb20473.x"},{"key":"e_1_2_6_41_1","first-page":"82","article-title":"Clinical pharmacokinetics in neonates","volume":"1","author":"Marselli PL","year":"1976","journal-title":"Clin Pharmacokinet"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920007779315053"},{"key":"e_1_2_6_43_1","first-page":"5509","article-title":"Age\u2010dependent tetrahydrothiophenium ion formation in young children and adults receiving high\u2010dose busulfan","volume":"57","author":"Gibbs JP","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_6_44_1","first-page":"10","volume-title":"Pediatric Pharmacology Therapeutic Principles in Practice","author":"Rane A","year":"1992"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196004212621601"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83507-3"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01223.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.06.011"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.02.005"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2011.577739"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2004.11.001"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.060137"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.2.355"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.2.361"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/dnares\/dsm018"},{"key":"e_1_2_6_56_1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.79.4.544","article-title":"Digoxin inactivation by the gut flora in infancy and childhood","volume":"79","author":"Linday L","year":"1987","journal-title":"Pediatrics"},{"key":"e_1_2_6_57_1","volume-title":"British National Formulary for Children (BNFC)","author":"Committee PF","year":"2012"},{"key":"e_1_2_6_58_1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/gas.37.7.792.798","article-title":"Metabolic characteristics of the faecal microflora in humans from three age groups","volume":"37","author":"Andrieux C","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050177"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2012.12.001"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/29.11.1196"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-303720"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443110-00002"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00491931"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8019.2000.00040.x"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-2105-4"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00866487"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2008.03.016"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0139"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0782-9"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2011.02.004"},{"key":"e_1_2_6_72_1","first-page":"18","article-title":"Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children","volume":"20","author":"Rodman JH","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.2174\/18715265112129990003"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2008.02.017"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.114835"},{"key":"e_1_2_6_76_1","unstructured":"FDA.Guidance for industry. Exposure\u2010response relationships \u2013 study design data analysis and regulatory applications. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER).2003; Available athttp:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm072109.pdf(last accessed 11 October 2013)."},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1529"},{"key":"e_1_2_6_78_1","unstructured":"EMA.Guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population Corrigendum. EMEA\/CHMP\/EWP\/147013\/20042006; Available athttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003066.pdf(last accessed 11 October 2013)."},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-0990-y"},{"key":"e_1_2_6_80_1","unstructured":"EMA.Guideline on the investigation of medicinal products in the term and preterm neonate. European Medicines Agency Commitee for medicinalproduicts for human use (CHMP) and paediatric committee (PDCO).2010. Available athttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003754.pdf(last accessed 11 October 2013)."},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(95)01303-3"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2011.07.016"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.177592"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3182587665"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06071-11"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1159\/000457062"},{"key":"e_1_2_6_87_1","unstructured":"FDA.Guidance for industry. Population pharmacokinetics. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER).1999; Available athttp:\/\/www.fda.gov\/downloads\/ScienceResearch\/SpecialTopics\/WomensHealthResearch\/UCM133184.pdf(last accessed 11 October 2013)."},{"key":"e_1_2_6_88_1","unstructured":"EMA.Guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population Committee for Medicinal Products for Human Use (CHMP).2007; Available athttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003066.pdf(last accessed 11 October 2013)."},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.9.1143"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847040-00002"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645090-00005"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0333-1"},{"key":"e_1_2_6_93_1","first-page":"907461","article-title":"Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development","volume":"2011","author":"L\u00e4er S","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03992.x"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.64"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-012-9241-9"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010510-100540"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.394"},{"key":"e_1_2_6_99_1","unstructured":"ReignerB.Clinical pharmacology considerations in paediatric development. \u2018Paediatric Clinical Trials meeting\u2019 SMi London March 20\u201321.2013."},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000221"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12267","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.12267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:37:57Z","timestamp":1746023877000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1111\/bcp.12267"],"URL":"https:\/\/doi.org\/10.1111\/bcp.12267","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,20]]}}}